Home NDC 43353-747 Furosemide
Product NDC 43353-747
11-digit product format 433530747
Labeler code 43353
Product ID 43353-747_13d5f0a8-f822-4190-99b3-32f2a1126caf
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Furosemide
Dosage form TABLET
Route ORAL
Labeler Aphena Pharma Solutions - Tennessee, LLC
Application NDA018823
Marketing category NDA
Marketing start 1983-11-10
Substance FUROSEMIDE
Active strength 20 mg/1
Pharmacologic classes Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018823-001 FUROSEMIDE FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 N018823-002 FUROSEMIDE FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N018823-001 FUROSEMIDE 20MG TABLET / ORAL AB 1983-11-10 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N018823-002 FUROSEMIDE 40MG TABLET / ORAL AB 1983-11-10 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Furosemide
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FUROSEMIDE 20 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7LXU5N7ZO5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 310429 Internal RxNorm lookup 313988 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43353-747-30 Furosemide 30 in 1 BOTTLE, PLASTIC TABLET 30 4 43353-747-45 Furosemide 45 in 1 BOTTLE, PLASTIC TABLET 45 4 43353-747-53 Furosemide 60 in 1 BOTTLE, PLASTIC TABLET 60 4 43353-747-60 Furosemide 90 in 1 BOTTLE, PLASTIC TABLET 90 4 43353-747-80 Furosemide 180 in 1 BOTTLE, PLASTIC TABLET 180 4 43353-747-92 Furosemide 270 in 1 BOTTLE, PLASTIC TABLET 270 4
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43353-747 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 4 Current NDC, Legacy NDC, 6 package rows 20180213_6fbf7f3d-7566-44d5-9507-c4460238fc91.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 43353-747-30 43353074730 30 TABLET in 1 BOTTLE, PLASTIC (43353-747-30) 30 tablet 2017-05-01 0000-00-00 No No Current 43353-747-45 43353074745 45 TABLET in 1 BOTTLE, PLASTIC (43353-747-45) 45 tablet 2017-08-22 0000-00-00 No No Current 43353-747-53 43353074753 60 TABLET in 1 BOTTLE, PLASTIC (43353-747-53) 60 tablet 2017-05-01 0000-00-00 No No Current 43353-747-60 43353074760 90 TABLET in 1 BOTTLE, PLASTIC (43353-747-60) 90 tablet 2011-08-02 0000-00-00 No No Current 43353-747-80 43353074780 180 TABLET in 1 BOTTLE, PLASTIC (43353-747-80) 180 tablet 2017-05-01 0000-00-00 No No Current 43353-747-92 43353074792 270 TABLET in 1 BOTTLE, PLASTIC (43353-747-92) 270 tablet 2017-08-22 0000-00-00 No No Current